Efficacy of biologic therapies for biologic-naïve Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis

BACKGROUND/AIMS: Several biologic therapies are approved in Japan to treat moderately to severely active ulcerative colitis (UC), but there are no published comparative efficacy studies in a Japanese population. We compared the efficacy of biologics approved in Japan (adalimumab, infliximab, golimum...

Descripción completa

Detalles Bibliográficos
Autores principales: Hibi, Toshifumi, Kamae, Isao, Pinton, Philippe, Ursos, Lyann, Iwakiri, Ryuichi, Hather, Greg, Patel, Haridarshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873404/
https://www.ncbi.nlm.nih.gov/pubmed/32312035
http://dx.doi.org/10.5217/ir.2019.09146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873404/
https://www.ncbi.nlm.nih.gov/pubmed/32312035
http://dx.doi.org/10.5217/ir.2019.09146

Ejemplares similares